Effect of Continuous Versus Cyclic Daytime Enteral Nutrition on Circadian Rhythms in Critical Illness
CIRCLES
1 other identifier
interventional
60
1 country
1
Brief Summary
Disruption of circadian rhythms is frequently observed in patients in the intensive care unit (ICU) and is associated with worse clinical outcomes. The ICU environment presents weak and conflicting timing cues to the circadian clock, including continuous enteral nutrition. The goal of this clinical trial is to evaluate the effect of timing of enteral nutrition on the circadian rhythm in critically ill patients. Patients admitted to the intensive care unit will be allocated to receive either continuous or cyclic daytime (8am to 8 pm) enteral feeding. Differences in circadian rhythms will be assessed by 24h patterns in core body temperature, heart rate variability, melatonin and peripheral clock gene expression. Secondary outcomes include depth of sleep, glucose variability and incidence of feeding intolerance. This study is expected to contribute to the optimalisation of circadian rhythms in the ICU.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 6, 2023
CompletedFirst Posted
Study publicly available on registry
April 3, 2023
CompletedStudy Start
First participant enrolled
June 14, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2025
CompletedMarch 20, 2025
March 1, 2025
1.8 years
March 6, 2023
March 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Amplitude of 24-h rhythm of core body temperature
Determined by cosinor analysis
Day 3 (8 a.m.) to day 4 (8 a.m.) after start of the study intervention (= start of enteral nutrition)
Acrophase 24-h rhythm of core body temperature
Determined by cosinor analysis
Day 3 (8 a.m.) to day 4 (8 a.m.) after start of the study intervention (= start of enteral nutrition)
Secondary Outcomes (18)
Amplitude of 24-h rhythm of plasma melatonin levels
Day 3 (8 a.m.) to day 4 (8 a.m.) after start of the study intervention (= start of enteral nutrition)
Acrophase of 24-h rhythm of plasma melatonin levels
Day 3 (8 a.m.) to day 4 (8 a.m.) after start of the study intervention (= start of enteral nutrition)
Amplitude of 24-h rhythm in heart rate variability
Day 3 (8 a.m.) to day 4 (8 a.m.) after start of the study intervention (= start of enteral nutrition)
Acrophase of 24-h rhythm in heart rate variability
Day 3 (8 a.m.) to day 4 (8 a.m.) after start of the study intervention (= start of enteral nutrition)
Amplitude of 24-h rhythm in systolic blood pressure
Day 3 (8 a.m.) to day 4 (8 a.m.) after start of the study intervention (= start of enteral nutrition)
- +13 more secondary outcomes
Study Arms (2)
Control group
NO INTERVENTIONcontinuous enteral nutrition: 24 hours a day (standard of care)
Intervention group
EXPERIMENTALcyclic daytime enteral nutrition: between 8 a.m. and 8 p.m. (same amount of nutrition as control group)
Interventions
The allocated feeding schedule is followed from the start of enteral nutrition after ICU admission until discharge from the ICU.
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years old
- Receiving of or intention to start enteral nutrition via nasogastric or nasoduodenal tube
- Arterial line
- Expected duration of ICU admission \> 48 hours
You may not qualify if:
- Receiving parenteral nutrition
- Chronic enteral tube feeding prior to current admission
- Presence of one or more contraindications of enteral feeding and/or at significant risk for gastrointestinal tolerance according to standard protocol (including but not limited to gastrointestinal haemorrhage, intestinal ischemia or necrosis, impaired digestive tract integrity due to obstruction or perforation, gastrectomy, enterectomy, history of gastroparesis or oesophageal dysmotility or expected surgery within 24 hours)
- Patients with glycaemic emergency (including but not limited to hyperglycaemic hyperosmolar nonketotic coma, diabetic ketoacidosis, severe hypoglycaemia resulting in ICU admission) or patients controlling their glucose levels and insulin dosing via continuous glucose monitoring
- Expected death within 24 hours
- Do-not-resuscitate (DNR) order
- Treatment with extracorporeal membrane oxygenation
- Severe neurological damage (significant neurological abnormalities such as bleeding, ischemia, neurotrauma or severe encephalopathy with Glasgow Coma Scale ≤ 8)
- Suspected or confirmed pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Leiden University Medical Center
Leiden, 2333ZA, Netherlands
Related Publications (2)
Kouw IWK, Heilbronn LK, van Zanten ARH. Intermittent feeding and circadian rhythm in critical illness. Curr Opin Crit Care. 2022 Aug 1;28(4):381-388. doi: 10.1097/MCC.0000000000000960. Epub 2022 Jul 5.
PMID: 35797531BACKGROUNDHiemstra FW, van Gent MF, de Jonge E, van Westerloo DJ, Kervezee L. Effect of cyclic daytime versus continuous enteral nutrition on circadian rhythms in critical illness (CIRCLES): Study protocol for a randomized controlled trial. Contemp Clin Trials. 2025 Jul;154:107927. doi: 10.1016/j.cct.2025.107927. Epub 2025 Apr 27.
PMID: 40300711DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David J van Westerloo, PhD, MD
Leiden University Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD PhD
Study Record Dates
First Submitted
March 6, 2023
First Posted
April 3, 2023
Study Start
June 14, 2023
Primary Completion
March 15, 2025
Study Completion
March 15, 2025
Last Updated
March 20, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- The data will be available immediately following publication.
- Access Criteria
- to be announced
Immediately following publication, the individual participant data that underlie the results reported in the published article will be shared after deidentificiation. The data will be shared upon request with researchers who wish to access the data for any purpose.